BeckRW, RiddlesworthT, RuedyK, et al.: Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA, 2017; 317:371–378.
2.
HaakT, HanaireH, AjjanR, et al.: Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther, 2017; 8:55–73.
3.
OlafsdottirAF, PolonskyW, BolinderJ, et al.: A randomized clinical trial of the effect of continuous glucose monitoring on nocturnal hypoglycemia, daytime hypoglycemia, glycemic variability, and hypoglycemia confidence in persons with type 1 diabetes treated with multiple daily insulin injections (GOLD-3). Diabetes Technol Ther, 2018; 20:274–284.
4.
BekiariE, KitsiosK, ThabitH, et al.: Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ, 2018; 361:k1310.
5.
BuckinghamBA, RaghinaruD, CameronF, et al.: Predictive low-glucose insulin suspension reduces duration of nocturnal hypoglycemia in children without increasing ketosis. Diabetes Care, 2015; 38:1197–1204.
6.
ForlenzaGP, LiZ, BuckinghamBA, et al.: Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial. Diabetes Care, 2018; 41:2155–2161.
7.
CastleJR, El YoussefJ, WilsonLM, et al.: Randomized outpatient trial of single- and dual-hormone closed-loop systems that adapt to exercise using wearable sensors. Diabetes Care, 2018; 41:1471–1477.
8.
DeBoerMD, ChernavvskyDR, TopchyanK, et al.: Heart rate informed artificial pancreas system enhances glycemic control during exercise in adolescents with T1D. Pediatr Diabetes, 2017; 18:540–546.
9.
BretonMD, ChernavvskyDR, ForlenzaGP, et al.: Closed-loop control during intense prolonged outdoor exercise in adolescents with type 1 diabetes: the artificial pancreas ski study. Diabetes Care, 2017; 40:1644–1650.
10.
FosterNC, BeckRW, MillerKM, et al.: State of type 1 diabetes management and outcomes from the T1D exchange in 2016–2018. Diabetes Technol Ther, 2019; 21:66–72.
11.
LiA, RiddellMC, PotashnerD, et al.: Time lag and accuracy of continuous glucose monitoring during high intensity interval training in adults with type 1 diabetes. Diabetes Technol Ther, 2019; 21:286–294.
12.
ZaharievaDP, TurksoyK, McGaughSM, et al.: Lag time remains with newer real-time continuous glucose monitoring technology during aerobic exercise in adults living with type 1 diabetes. Diabetes Technol Ther, 2019; 21:313–321.
13.
LaroseS, Rabassa-LhoretR, Roy-FlemingA, et al.: Changes in accuracy of continuous glucose monitoring using Dexcom G4 Platinum over the course of moderate intensity aerobic exercise in type 1 diabetes. Diabetes Technol Ther, 2019; 21:364–369.
14.
ForlenzaGP, BuckinghamBA, ChristiansenMP, et al.: Performance of Omnipod personalized model predictive control algorithm with moderate intensity exercise in adults with type 1 diabetes. Diabetes Technol Ther, 2019; 21:265–272.
15.
HomePD: The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences. Diabetes Obes Metab, 2012; 14:780–788.
16.
McMahonSK, FerreiraLD, RatnamN, et al.: Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. J Clin Endocrinol Metab, 2007; 92:963–968.
17.
RiddellMC, GallenIW, SmartCE, et al.: Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol, 2017; 5:377–390.
18.
KropffJ, van SteenSC, deGraaffP, et al.: Venous, arterialized-venous, or capillary glucose reference measurements for the accuracy assessment of a continuous glucose monitoring system. Diabetes Technol Ther, 2017; 19:609–617.
19.
PleusS, SchoemakerM, MorgensternK, et al.: Rate-of-change dependence of the performance of two CGM systems during induced glucose swings. J Diabetes Sci Technol, 2015; 9:801–807.
20.
CobelliC, SchiavonM, Dalla ManC, et al.: Interstitial fluid glucose is not just a shifted-in-time but a distorted mirror of blood glucose: insight from an in silico study. Diabetes Technol Ther, 2016; 18:505–511.
21.
MoserO, YardleyJE, BrackenRM: Interstitial glucose and physical exercise in type 1 diabetes: integrative physiology, technology, and the gap in-between. Nutrients, 2018; 10:E93.
22.
BasuR, JohnsonML, KudvaYC, et al.: Exercise, hypoglycemia, and type 1 diabetes. Diabetes Technol Ther, 2014; 16:331–337.
23.
BasuA, DubeS, SlamaM, et al.: Time lag of glucose from intravascular to interstitial compartment in humans. Diabetes, 2013; 62:4083–4087.
24.
NakamuraK, BaloA: The accuracy and efficacy of the Dexcom G4 platinum continuous glucose monitoring system. J Diabetes Sci Technol, 2015; 9:1021–1026.
25.
MatulevicieneV, JosephJI, AndelinM, et al.: A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes. Diabetes Technol Ther, 2014; 16:759–767.
26.
PeyserTA, NakamuraK, PriceD, et al.: Hypoglycemic accuracy and improved low glucose alerts of the latest Dexcom G4 platinum continuous glucose monitoring system. Diabetes Technol Ther, 2015; 17:548–554.
27.
ShahVN, LaffelLM, WadwaRP, et al.: Performance of a factory-calibrated real-time continuous glucose monitoring system utilizing an automated sensor applicator. Diabetes Technol Ther, 2018; 20:428–433.
28.
MoserO, EcksteinML, MuellerA, et al.: Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with type 1 diabetes: a randomized crossover trial. Diabet Med, 2019; 36:606–611.
